img
Effect of candesartan treatment on echocardiographic indices of cardiac remodeling in post-myocardial infarction patients      
Yazarlar
Hüseyin Tezcan
Türkiye
Abdullah Tunçez
Selçuk Üniversitesi, Türkiye
Kenan Demir
Türkiye
Bülent Behlül Altunkeser
Türkiye
Nazif Aygül
Türkiye
Muhammed Ulvi Yalçın
Selçuk Üniversitesi, Türkiye
Dr. Öğr. Üyesi Muhammet Salih ATEŞ
Kırşehir Ahi Evran Üniversitesi, Türkiye
Onur Can Polat
Aslıhan Merve Toprak
Canan Aydoğan
Özet
Objective: Myocardial infarction has unfavorable effect on structural and functional properties of the myocardium, referred to as cardiac remodeling. Left ventricular mass, left ventricular mass index, and relative wall thickness are important predictors of cardiac remodeling. In this study, we investigated the effect of candesartan treatment in comparison with zofenopril treatment on echocardiographic indices of cardiac remodeling in post myocardial infarction patients. Material and Methods: In this prospective study, patients who underwent successful percutaneous coronary intervention were randomly assigned to a candesartan or zofenopril treatment. After randomization, echocardiographic indices of cardiac remodeling including left ventricular mass, left ventricular mass index, and relative wall thickness were evaluated before the start of treatment along with 1 -and 6-month follow-ups. Results: According to our study, candesartan group showed significant reduction of estimated left ventricular mass and left ventricular mass index at 6-month follow-up visit compared to baseline values (199.53 +/- 38.51 g vs. 212.69 +/- 40.82 g; 99.05 g/m(2) (90.00-116.5) vs. 106.0 g/m(2) (96.0 similar to 123.00), p<0.05, respectively). This trend was also observed in zofenopril group during the 6-month period (201.22 +/- 40.07 g vs. 207.52 +/- 41.61 g; 101.0 g/ m(2) (92.25-111.75.0) vs. 104.50 g/m(2) (95.0 similar to 116.75), p<0.05, respectively). Although both classes of drugs had favorable effects on post-myocardial infarction cardiac remodeling, the absolute benefit was more prominent in candesartan group as compared to zofenopril group (p<0.05). Conclusion: Our results suggest that candesartan treatment following myocardial infarction may potentially be useful in terms of improving post -myocardial infarction cardiac remodeling.
Anahtar Kelimeler
Myocardial infarction, Cardiac remodeling, Candesartan treatment
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı FapUNIFESP (SciELO)
Dergi ISSN 0104-4230
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili Türkçe
Basım Tarihi 01-2023
Cilt No 69
Sayı 1
Sayfalar 78 / 84
Doi Numarası 10.1590/1806-9282.20220720
Makale Linki http://dx.doi.org/10.1590/1806-9282.20220720